Bioequivalence Study of SB797620 in Healthy Japanese Volunteers

NCT00549263 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No subjects enrolled, bio equivalence study, canceled before active.

Conditions

Healthy Subjects

Interventions

DRUG: SB797620

Sponsor

GlaxoSmithKline